HIV-1 Nef regulates the release of superoxide anions from human macrophages
- 23 August 2005
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 390 (2) , 591-602
- https://doi.org/10.1042/bj20042139
Abstract
The NADPH oxidase enzymatic complex participates in the oxidative burst by producing ROS (reactive oxygen species). Altered levels of ROS production may have pathogenetic implications due to the loss of some innate immune functions such as oxidative burst and phagocytosis. Considering that HIV-1 Nef protein plays a primary role in AIDS pathogenesis, by affecting the immune system, we sought to dissect possible effects of Nef on the release of superoxide anions. We show here that the inducible expression of Nef in human phagocytic cells modulates the superoxide release in a biphasic manner. In particular, an early Nef-induced increase of the superoxide release was followed by a dramatic decrease starting from 10 h after the Nef induction. This was observed whatever the presence of cell activators such as GM-CSF (granulocyte/macrophage colony-stimulating factor) or fMLP (N-formyl-L-methionyl-L-leucyl-L-phenylalanine). Whereas the early increase in superoxide release is probably the result of the already described Nef-dependent activation of PAK-2 (p21-activated kinase 2)–Rac2, we were interested in investigating the mechanisms underlying the late inhibition of superoxide release observed originally. In this regard, we individuated at least three independent requirements for the Nef-induced blockade of superoxide release: (i) the active protein synthesis; (ii) both the membrane localization and the interaction with endocytotic machinery of Nef; and (iii) the release of soluble factor(s). Moreover, we observed that IL-10 (interleukin-10) inhibits superoxide release, whereas its depletion restored NADPH oxidase activity. We propose that the cell membrane-to-lysosome Nef transit leads to the synthesis and release of soluble factor(s) and, among them, IL-10 might significantly contribute to the inhibition of NAPDH oxidase activity.Keywords
This publication has 57 references indexed in Scilit:
- Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machineryJournal of Leukocyte Biology, 2003
- Exogenous Nef Protein Activates NF-κB, AP-1, and c-Jun N-Terminal Kinase and Stimulates HIV Transcription in Promonocytic CellsJournal of Biological Chemistry, 2003
- The HIV-1 Nef Protein and Phagocyte NADPH Oxidase ActivationJournal of Biological Chemistry, 2002
- Impaired Macrophage Phagocytosis of Apoptotic Neutrophils in Patients with Human Immunodeficiency Virus Type 1 InfectionClinical and Vaccine Immunology, 2002
- Design and Use of an Inducibly Activated Human Immunodeficiency Virus Type 1 Nef To Study Immune ModulationJournal of Virology, 2001
- Neutrophil priming: the cellular signals that say ‘amber’ but not ‘green’Immunology Today, 1995
- Human Immunodeficiency Virus Type 1 Infection of Human Monocytes and Macrophages Does Not Alter Their Ability to Generate an Oxidative BurstThe Journal of Infectious Diseases, 1993
- Amplification of superoxide anion generation in phagocytic cells by HIV‐1 infectionFEBS Letters, 1993
- Differentiation of the U-937 promonocytic cell line induced by phorbol myristate acetate or retinoic acid: Effect of aurothiomalateInflammation Research, 1992
- Importance of the nef gene for maintenance of high virus loads and for development of AIDSCell, 1991